Vermillion, Inc.
(NASDAQ : VRML)

( )
VRML PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.12%196.411.2%$567.51m
TSROTESARO, Inc.
0.08%74.3114.4%$551.02m
CELGCelgene Corporation
2.03%70.901.2%$541.17m
GILDGilead Sciences, Inc.
0.62%68.140.9%$521.04m
BIIBBiogen Inc.
0.88%322.611.3%$364.53m
ILMNIllumina, Inc.
2.44%336.923.5%$356.07m
REGNRegeneron Pharmaceuticals, Inc.
0.60%377.962.6%$267.70m
AAgilent Technologies, Inc.
0.99%71.751.5%$240.96m
VRTXVertex Pharmaceuticals Incorporated
1.28%175.451.9%$234.92m
ALXNAlexion Pharmaceuticals, Inc.
1.90%117.012.0%$146.65m
SRPTSarepta Therapeutics, Inc.
0.10%125.1315.4%$110.90m
INCYIncyte Corporation
3.16%67.672.5%$104.86m
EXASExact Sciences Corporation
3.27%71.7925.3%$97.81m
NKTRNektar Therapeutics
1.48%36.975.5%$91.00m
SGENSeattle Genetics, Inc.
1.66%61.956.6%$85.00m

Company Profile

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.